• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
    • News & Updates
  • Donate
Home / Ask the Expert / Cancer, psoriatic arthritis, and anti-TNF drugs (Enbrel, Humira, Remicade, etc)

Cancer, psoriatic arthritis, and anti-TNF drugs (Enbrel, Humira, Remicade, etc)

October 22, 2009 By Arthritis Center

Question

I was diagnosed with Psoriatic Arthiritis Dec of 08 have been on methoraxate my crp levels started to go down but all of a sudden went back up. My doctor has started me on Humira. My concern is that I had cancer 12 years ago will the Humira cause a reoccurance. My doctor says we will monitor it very closly.

Answer

HI Virgil,

Several hundreds of thousand of patients with various inflammatory types of arthritis have not taken one or more of the anti-TNF drugs (humira, enbrel, remicade).  We feel fairly certain based on all of these data that these drugs do not increase the risk of most tumors like breast, colon, prostate, stomach, kidney.  However, there is a lingering concern that they could increase the risk for lymph node cancers (lymphomas) but this is debatable because at least one type of inflammatory arthritis (rheumatoid arthritis) itself causes increased risk of lymphoma.  So, it might be the disease not the drug.  There have also been reports that these agents could possibly increase risk for skin cancers, but this isn’t definitive yet either.  Each patient has to weigh the potential destructiveness of the arthritis against the relatively small chance that the drug might increase risk of a cancer.

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2025 Johns Hopkins Arthritis Center
Patient Privacy